Ratio Therapeutics

Ratio Therapeutics is an early clinical-stage drug research and development and manufacturing company that utilizes a set of innovative technologies to develop best-in-class targeted radiopharmaceuticals for cancer treatment. Ratio Therapeutics' Trillium™ Targeting Scaffold combines pharmacokinetic modulation with first-class chelation technology to create proprietary small-molecule targeting agents to attack a wide range of cancer targets.